Analysts: Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

6.87USD
1 Aug 2013
Price Change (% chg)

$-0.08 (-1.15%)
Prev Close
$6.95
Open
$7.15
Day's High
$7.15
Day's Low
$6.82
Volume
1,296,797
Avg. Vol
1,064,672
52-wk High
$10.99
52-wk Low
$6.65

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.07 December 1 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 6 6 6 6
(4) UNDERPERFORM 2 2 2 2
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 3.09 3.09 3.09 3.09

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 11 12.48 66.60 4.50 19.63
Quarter Ending Dec-13 11 10.86 20.81 5.69 35.33
Year Ending Dec-13 11 83.28 100.60 24.60 57.67
Year Ending Dec-14 11 96.37 175.40 47.84 136.87
Earnings (per share)
Quarter Ending Sep-13 11 -0.07 0.17 -0.12 -0.05
Quarter Ending Dec-13 11 -0.10 -0.05 -0.13 -0.01
Year Ending Dec-13 9 -0.10 -0.08 -0.15 -0.17
Year Ending Dec-14 11 -0.17 0.14 -0.37 0.09

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 44.45 2.37 42.08 94.66
Quarter Ending Dec-12 17.43 1.94 15.50 88.90
Quarter Ending Sep-12 3.51 1.49 2.03 57.69
Quarter Ending Jun-12 10.07 21.98 11.91 118.34
Quarter Ending Mar-12 2.65 2.19 0.46 17.44
Earnings (per share)
Quarter Ending Mar-13 0.09 -0.09 0.18 204.17
Quarter Ending Dec-12 -0.03 -0.10 0.07 -257.14
Quarter Ending Sep-12 -0.09 -0.07 0.02 -18.22
Quarter Ending Jun-12 -0.07 -0.12 0.05 -77.78
Quarter Ending Mar-12 -0.12 -0.18 0.06 -44.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 12.48 12.39 12.39 12.39 19.63
Quarter Ending Dec-13 10.86 10.81 10.81 10.81 35.33
Year Ending Dec-13 83.28 82.74 82.74 82.74 57.67
Year Ending Dec-14 96.37 95.39 95.39 95.39 136.87
Earnings (per share)
Quarter Ending Sep-13 -0.07 -0.07 -0.07 -0.07 -0.05
Quarter Ending Dec-13 -0.10 -0.10 -0.10 -0.10 -0.01
Quarter Ending Dec-13 -0.10 -0.11 -0.11 -0.11 -0.17
Quarter Ending Dec-14 -0.17 -0.17 -0.17 -0.17 0.09

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 1 0 1 0
Quarter Ending Dec-13 1 0 1 0
Year Ending Dec-13 1 0 1 0
Year Ending Dec-14 1 0 1 0
Earnings
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 1 0 1 0
Year Ending Dec-14 1 0 1 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks